Category: CBSA News

Weekly Policy Update: Action on Two Bills and Advocacy in DC

By: Colorado BioScience Association   Date: 04/20/2018

UNDER THE GOLD DOME This week, HB18-1135: Extend Advanced Industry Export Acceleration Program passed the Colorado House of Representatives and next week it moves to the Senate. This bill extends the...

Learn More

Colorado BioScience Association Names New Board Members

By: Colorado BioScience Association   Date: 04/20/2018

Leaders represent CereScan, Ocugen, Prevacept Infection Control, Sharklet and Zimmer Biomet DENVER – April 23, 2018 – Colorado BioScience Association (CBSA) announces new members elected to its board...

Learn More

Driving Down Drug Costs

By: Colorado BioScience Association   Date: 04/16/2018

Three Solutions to Help Patients and Support Innovators Current proposals under consideration at the Colorado State Legislature propose a simple fix for a complex issue. We agree, patients and their f...

Learn More

Weekly Policy Update: CBSA Takes Positions on Additional Bills, Transparency News, and China Tariffs

By: Colorado BioScience Association   Date: 04/13/2018

UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation...

Learn More

Weekly Policy Update: CO House Votes on Prescription Drug Price Transparency Bill Monday!

By: Colorado BioScience Association   Date: 04/06/2018

Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle...

Learn More

Understanding Bills at the Legislature

By: Colorado BioScience Association   Date: 04/02/2018

Where Do Patients Fit In? Colorado families need access to medicines and health care at affordable prices. That’s why Colorado BioScience Association supports True Transparency. This means considering...

Learn More

Weekly Policy Update: Colorado Budget and Forecast, plus a True Transparency update

By: Colorado BioScience Association   Date: 03/30/2018

CO State Budget & March Forecast Transportation, Education, PERA, and opioid addiction are a few of the areas that will receive funding in the $28.9 billion state budget package passed by the Colo...

Learn More

How do drug companies determine prices?

By: Colorado BioScience Association   Date: 03/26/2018

The Value of Innovation When you stop in to the pharmacy to pick up a prescription, you may wonder how manufacturers determine the price you pay. You may think the drug maker maintains full control ov...

Learn More

Weekly Policy Update: Advocacy Around Drug Transparency Issues, an Opportunity To Be Heard By the Next Governor, and the Omnibus Spending Bill

By: Colorado BioScience Association   Date: 03/23/2018

This week CBSA testified in opposition to House Bill 1009, Diabetes Drug Pricing Transparency Act 2018. The bill was heard in the House Health, Insurance and Environment Committee and passed on a part...

Learn More

What are Pharmacy Benefit Managers?

By: Colorado BioScience Association   Date: 03/19/2018

PBMs Largely Determine How Much Your Medicines Cost With public policy debate at Colorado’s State Capitol focused on prescription drug price transparency, it’s critical for our decision makers and the...

Learn More